How to Choose an Imaging Provider for Your Clinical Trial
Medical Imaging plays an important role in the clinical development of new drugs. In non-alcoholic steatohepatitis (NASH) specifically, it is one of the most c…
22 Sep 2020
Beyond the Biopsy
Perspectum is a proud sponsor and supporter of the Global Liver Institute's Beyond the Biopsy initiative and its mission to accelerate the acceptance and adopt…
8 Sep 2020
Perspectum Partners with UT Southwestern Medical Center on Dallas Heart & Minds Study
Dallas, Texas, August 18, 2020 - Perspectum® is proud to announce a collaboration with UT Southwestern Medical Center, to include LiverMultiScan® technology …
18 Aug 2020
Multiparametric MRI: bridging the diagnostic gap for liver disease
Oxford, August 7th, 2020. A review of techniques for clinical decision making in diffuse liver disease, published this week in Abdominal Radiology, highlights …
7 Aug 2020
Meet the team: Improving Outcomes through Customer Success
Our mission is to improve the lives of patients. We do this by building best-in-class technologies and working collaboratively with our customers to bring thos…
6 Aug 2020
Quantitative MRI; a game changer for identifying the chronic liver disease patients most at risk of poor clinical outcomes
Oxford, August 6th, 2020. Perspectum’s cT1® is the best non-invasive predictor of clinical outcomes in chronic liver disease (CLD) patients, new research pu…
4 Aug 2020
The link between type 2 diabetes and liver disease: can screening for NAFLD reduce liver-related mortality?
Oxford, July 23, 2020. A review of screening modalities and treatment options for individuals with type 2 diabetes and non-alcoholic fatty liver disease (NAFLD…
23 Jul 2020
Perspectum expands AI and imaging CRO portfolio with Cardiac Imaging
San Francisco, Oxford, July 15, 2020. Perspectum, a leading medical imaging company, has begun work on expanding its offering by including cardiac and lung ima…
16 Jul 2020
Perspectum Launches Multi-Site NASH Study to Accelerate Patient Enrollment
Dallas, Texas, July 7, 2020 – Perspectum is collaborating with top medical institutions to evaluate the diagnostic performance of their flagship product, Liv…
7 Jul 2020
Perspectum partners in a multimillion pound research project (ID-LIVER) to help prevent patients from developing liver cancer
Oxford, England, 3rd July 2020 Perspectum are proud to announce a new partnership to improve the lives of patients with liver disease by providing earlier and …
3 Jul 2020
High liver fat associated with a higher risk for severe COVID-19
Oxford, Jun 21, 2020. High liver fat is associated with a higher risk of developing more severe COVID-19 infection, new research finds. Scientists from Pers…
21 Jun 2020
Going Beyond the Biopsy & Adopting Noninvasive Technologies
Did you know millions of people across the world are affected by a silent disease that is damaging their internal organs and often goes undetected until it is …
8 Jun 2020